Multi drug resistant tuberculosis is resistance to?
## **Core Concept**
Multi-drug resistant tuberculosis (MDR-TB) is a type of tuberculosis infection caused by bacteria that are resistant to treatment with at least two of the most powerful first-line anti-TB drugs. The primary drugs to which resistance is tested for defining MDR-TB are isoniazid and rifampicin.
## **Why the Correct Answer is Right**
MDR-TB is defined by resistance to at least both **isoniazid (H)** and **rifampicin (R)**, which are the two most potent first-line drugs used in the treatment of tuberculosis. This dual resistance makes the standard six-month treatment regimen ineffective, requiring longer treatment periods with more toxic and less effective second-line drugs. The mechanism of resistance often involves mutations in specific genes of the Mycobacterium tuberculosis complex, such as the katG gene for isoniazid resistance and the rpoB gene for rifampicin resistance.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Resistance to only one drug does not classify as MDR-TB. Resistance to a single drug can still be effectively managed with adjusted first-line regimens or the addition of a single second-line drug.
- **Option B:** While resistance to isoniazid and another drug could be problematic, MDR-TB specifically requires resistance to both isoniazid and rifampicin. Resistance to other drugs, even if multiple, does not meet the criteria if rifampicin is still susceptible.
- **Option C:** This option might imply resistance to drugs other than or in addition to isoniazid and rifampicin, which does not define MDR-TB but could describe extensively drug-resistant TB (XDR-TB) or other forms of drug-resistant TB.
## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **MDR-TB is primarily identified by resistance to isoniazid and rifampicin**. This definition is crucial for treatment planning and public health response. Clinicians must consider drug susceptibility testing (DST) results for these two drugs when diagnosing and managing TB.
## **Correct Answer:** B. Isoniazid and Rifampicin.